Shree Ganesh Remedies Reports Weak Q2FY27 Results Amid Input Cost Pressures
Shree Ganesh Remedies Ltd · Press Release · 02 Nov 2026, 12:37 am
Shree Ganesh Remedies Reports Weak Q2FY27 Results Amid Input Cost Pressures Shree Ganesh Remedies reported a challenging Q2FY27, with revenue declining 23% YoY to ₹23.29 Cr, EBITDA dropping 59% YoY to ₹3.94 Cr, and PAT falling 67% YoY to ₹1.63 Cr. EBITDA margins contracted 1,483 bps YoY to 16.9%, impacted by volatile raw material costs and subdued European demand. However, performance rebounded QoQ, with revenue rising 62% and PAT gaining 46%. H1FY27 revenue and PAT stood at ₹37.65 Cr and ₹2.75 Cr, down 32% and 67% YoY, respectively. Construction of Block 7A is completed to support its expanding CRAMS pipeline.
Original exchange filing (PDF)
More announcements from Shree Ganesh Remedies Ltd
- Audio Recording - Earnings Call held on November 14, 2026 · 15 Nov 2026
- Intimation for invitation of Earnings Conference Call · 14 Nov 2026
- Investor Presentation · 02 Nov 2026
- Financial Results for quarter and half year ended September 30, 2026 · 01 Nov 2026
- Outcome of Board Meeting · 31 Oct 2026
- Shree Ganesh Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/10/2026 ,inter alia, to consider and approve The Unaudited Financial .... · 31 Oct 2026
- Appointment of Company Secretary and Compliance Officer · 04 Oct 2026
- Resignation of Company Secretary / Compliance Officer · 04 Oct 2026
